*No mesh is indicated for use in infected or contaminated fields.
Let’s talk about adding Phasix™ Mesh to your practice.
Sales Form
Please fill out the form and a sales representative will get in touch with you.
Proven clinical outcomes at 5 years1-3
40+ Clinical studies4
Over 185,000 implants globally5
More than 3,000 patients studied4
In a longitudinal 5-year follow up of 73 complex abdominal wall reconstruction patients, Phasix™ Mesh demonstrated lower recurrence, SSI and complication rates compared to Strattice™ Tissue Matrix.1
In this prospective, multi-institutional study evaluating P4HB VIHR in comorbid patients with CDC Class I wounds, five-year outcomes following VIHR with P4HB mesh were associated with infrequent complications and durable hernia repair outcomes.2
In a longitudinal 5-year follow up of 43 ventral hernia repair (VHR) patients, reported quality of life following VHR with Phasix™ Mesh improved immediately and continued to improve 5 years following repair.3